Cerevel Therapeutics Hldg Inc (CERE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CERE | CTLT | MDGL | ||
| Company | Cerevel Therapeutics Hldg Inc | Catalent Inc | Madrigal Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 44.99 | 59.09 | 318.42 | ||
| High | 44.99 | 59.84 | 329.93 | ||
| Low | 44.96 | 58.92 | 315.15 | ||
| Last | 44.96 | 59.66 | 329.24 | ||
| Change | +0.33 | +0.66 | +12.15 | ||
| % Change | +0.74% | +1.12% | +3.83% | ||
| Volume | 15,096,300 | 1,190,014 | 423,608 | ||
| 20-Day Average Volume | 2,839,210 | 1,753,676 | 670,525 | ||
| Previous Close | 44.63 | 59.00 | 317.09 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 42.53 | 59.08 | 300.11 | ||
| 20-Day Raw Stochastic | 99.49% | 71.28% | 76.35% | ||
| 20-Day Relative Strength | 68.05% | 52.16% | 64.76% | ||
| Weighted Alpha | +49.03 | +38.28 | +24.92 | ||
| Today's Opinion | 72% Buy | 40% Buy | 72% Buy | ||
| Previous Opinion | 72% Buy | 8% Buy | 72% Buy | ||
| Last Month's Opinion | 8% Buy | 56% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.67% since 07/24/24 | +1.27% since 11/14/24 | +8.78% since 11/14/24 | ||
| Low | 43.75 on 07/25/24 | 58.39 on 11/19/24 | 272.72 on 11/15/24 | ||
| High | 44.99 on 07/31/24 | 59.84 on 11/21/24 | 329.93 on 11/21/24 | ||
| 1-Month | |||||
| %Chg | +9.95% since 06/28/24 | -0.86% since 10/21/24 | +57.61% since 10/21/24 | ||
| Low | 39.16 on 07/03/24 | 58.29 on 11/05/24 | 200.63 on 10/23/24 | ||
| High | 44.99 on 07/31/24 | 60.32 on 10/22/24 | 368.29 on 11/07/24 | ||
| 3-Month | |||||
| %Chg | +5.27% since 04/30/24 | +0.42% since 08/21/24 | +28.52% since 08/21/24 | ||
| Low | 38.50 on 06/25/24 | 58.29 on 11/05/24 | 200.63 on 10/23/24 | ||
| High | 44.99 on 07/31/24 | 61.20 on 08/30/24 | 368.29 on 11/07/24 | ||
| 6-Month | |||||
| %Chg | +6.82% since 01/30/24 | +8.55% since 05/21/24 | +35.77% since 05/21/24 | ||
| Low | 38.50 on 06/25/24 | 53.51 on 05/29/24 | 200.63 on 10/23/24 | ||
| High | 44.99 on 07/31/24 | 61.20 on 08/30/24 | 368.29 on 11/07/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,191,488 | 10,709,208 | 6,915,730 | ||
| Shares Outstanding, K | 182,195 | 181,512 | 21,810 | ||
| Annual Sales | 0 | 4,381,000,000 | 0 | ||
| Annual Net Income | -432,840,000 | -1,043,000,000 | -373,630,000 | ||
| Last Quarter Sales | 0 | 1,023,000,000 | 62,180,000 | ||
| Last Quarter Net Income | -131,910,000 | -129,000,000 | -106,960,000 | ||
| 60-Month Beta | 1.40 | 1.16 | -0.46 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.73 on 05/08/24 | -0.13 on 11/05/24 | -4.92 on 10/31/24 | ||
| Latest Earnings Date | 08/07/24 | 11/20/24 | 10/31/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||